Related Experiment Video
Updated: Nov 16, 2025

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Fulminant COVID-19-Associated Myocarditis in an Otherwise Healthy Female
Gabriela C Milla-Godoy1, Robin Park1, Weizheng Jiang1
1Internal Medicine, MetroWest Medical Center, Tufts University School of Medicine, Framingham, USA.
Insights
This case study details a healthy 45-year-old female with severe COVID-19 presenting with only gastrointestinal symptoms. She rapidly developed myocarditis and cardiogenic shock, highlighting atypical severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presentations.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, has led to diverse clinical manifestations.
- Myocarditis, or heart muscle inflammation, is a known but less common complication of SARS-CoV-2 infection.
- Atypical presentations of COVID-19 can delay diagnosis and treatment, potentially worsening outcomes.
Observation:
- A 45-year-old healthy female presented with exclusively gastrointestinal symptoms, initially masking a potential SARS-CoV-2 infection.
- Electrocardiogram (EKG) revealed ST-segment elevations, and laboratory tests showed elevated troponin levels, indicative of cardiac injury.
- A positive SARS-CoV-2 reverse transcription-polymerase chain reaction (RT-PCR) test confirmed the infection.
Findings:
- The patient experienced rapid clinical deterioration within hours of hospital admission.
- She developed cardiogenic shock, a life-threatening condition where the heart cannot pump enough blood to meet the body's needs.
- This indicated a severe form of COVID-19-associated myocarditis.
Implications:
- This case underscores the importance of considering COVID-19 in patients presenting with atypical symptoms, including gastrointestinal distress.
- Fulminant myocarditis and cardiogenic shock can be rare but severe complications of SARS-CoV-2 infection.
- Early recognition and aggressive management are crucial for improving outcomes in patients with severe COVID-19-associated cardiac complications.
Abstract:
An outbreak of a severe respiratory illness caused by a novel coronavirus that began in China in late 2019 has become a pandemic. We report the case of COVID-19-associated myocarditis in a 45-year-old healthy female who presented with solely gastrointestinal symptoms. Initial investigations revealed ST-segment elevations in her electrocardiogram (EKG), elevated troponin levels, and a positive severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) reverse transcription-polymerase chain reaction (RT-PCR). Subsequently, she had rapid deterioration with the development of cardiogenic shock within hours of admission to a community hospital in Massachusetts. This case highlights an atypical presentation of COVID-19 with a fulminant course in this emerging and evolving disease.
More Related Videos
08:52Author Spotlight: Developing a Translational Model for Atrial Fibrillation Research Across Species
Published on: November 21, 2023
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Pericarditis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy